KV PHARMACEUTICAL CO /DE/·4

Jan 14, 5:00 PM ET

MITCHELL GERALD R 4

4 · KV PHARMACEUTICAL CO /DE/ · Filed Jan 14, 2004

Insider Transaction Report

Form 4
Period: 2004-01-12
MITCHELL GERALD R
Vice President and CFO
Transactions
  • Gift

    Class A Common Stock

    2004-01-122,98534,340 total
  • Exercise/Conversion

    Class A Common Stock

    2004-01-12$4.43/sh+2,000$8,86637,325 total
  • Exercise/Conversion

    Class B Common Stock

    2004-01-12$4.45/sh+1,250$5,56470,385 total
  • Exercise/Conversion

    Option to Purchase

    2004-01-12$4.45/sh1,250$5,5647,240 total
    Exercise: $4.45From: 2001-08-15Exp: 2007-09-15Class B Common Stock (1,250 underlying)
  • Exercise/Conversion

    Option to Purchase

    2004-01-12$4.43/sh2,000$8,8666,435 total
    Exercise: $4.43From: 2001-08-15Exp: 2007-09-15Class A Common Stock (2,000 underlying)
Footnotes (1)
  • [F1]Shares reported on Table 1 reflect a 3-for-2 stock split in form of stock dividend distributed 9/29/03

Documents

1 file
  • 4
    kvf4mitch011404_ex.xmlPrimary